• Have a question?
    Open from 8am to 7pm Monday to Friday    Call customer services
    0345 54 32 600


| Print

Exact Sciences Corp (EXAS)

Common Shares
Sell: $62.66|Buy: $63.45|Change: 1.50 (2.45%)

Not yet a customer?

Low cost dealing from £1.50

Choose from our range of SIPP, ISA and Dealing accounts

Find out more

This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPP

Company profile

Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test is a noninvasive stool-based DNA test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, aliquid-based comprehensive genomic profiling test. It also has a pipeline of blood-based tests for molecular residual disease, colorectal cancer screening, and multicancer screening.

Address

441 Charmany Drive
Madison
WI
USA
53719

Telephone

+1 608 5358815

Website

https://www.exactsciences.com

Sector 

Healthcare

Forecast key dates

NameKey Date
Exact Sciences Corp Second Quarter Earnings Conference Call for 20262026-08-06T17:00:00
Exact Sciences Corp Second Quarter Earnings Results for 20262026-08-06T00:00:00
Exact Sciences Corp Annual General Meeting for 20262026-06-12T10:00:00
Exact Sciences Corp First Quarter Earnings Conference Call for 20262026-05-01T17:00:00
Exact Sciences Corp First Quarter Earnings Results for 20262026-05-01T00:00:00
Exact Sciences Corp Fourth Quarter Earnings Conference Call for 20252026-02-19T17:00:00
Exact Sciences Corp Fourth Quarter Earnings Results for 20252026-02-19T00:00:00
Exact Sciences Corp Annual Report for 20252026-02-19T00:00:00
Exact Sciences Corp Third Quarter Earnings Conference Call for 20252025-11-03T17:00:00
Exact Sciences Corp Third Quarter Earnings Result for 20252025-11-03T00:00:00

Previous key dates

NameKey Date
Baird Global Healthcare Conference2025-09-09T10:50:00
Wells Fargo Healthcare Conference2025-09-03T13:30:00
Exact Sciences Corp Second Quarter Earnings Conference Call for 20252025-08-06T17:00:00
Exact Sciences Corp Second Quarter Earnings Result for 20252025-08-06T00:00:00
Exact Sciences Corp Annual General Meeting for 20252025-06-12T10:00:00
William Blair 45th Annual Growth Stock Conference2025-06-03T09:40:00
BofA Securities Health Care Conference2025-05-14T13:40:00
Exact Sciences Corp First Quarter Earnings Conference Call for 20252025-05-01T17:00:00
Exact Sciences Corp First Quarter Earnings Results for 20252025-05-01T00:00:00
Raymond James Institutional Investors Conference2025-03-04T13:05:00
TD Cowen Health Care Conference2025-03-03T10:30:00
Exact Sciences Corp Fourth Quarter Earnings Conference Call for 20242025-02-19T17:00:00
Exact Sciences Corp Fourth Quarter Earnings Result for 20242025-02-19T00:00:00
Exact Sciences Corp Annual Report for 20242025-02-19T00:00:00
J.P. Morgan Healthcare Conference2025-01-13T13:30:00
Evercore HealthCONx Conference2024-12-04T07:30:00
Citi Global Healthcare Conference2024-12-03T08:45:00
Exact Sciences to Participate in Jefferies London Healthcare Conference, London2024-11-19T17:00:00
Exact Sciences Corp Third Quarter Earnings Conference Call for 20242024-11-05T17:00:00
Exact Sciences Corp Third Quarter Earnings Result for 20242024-11-05T00:00:00

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2025 AJ Bell. All rights reserved.